SCHEDULE 13G

Company

Cellectar Biosciences, Inc.

Filed

May 24, 2019

Accession Number

0001213900-19-009528

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →